Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(4)
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Approval
|
Mid-range Performer
369.2000
0.80
(
0.22
%)
NSE
Sep 19, 2025
15:31 PM
26.87% Gain from 52W Low
Volume:
14.2M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
17 May 2024
US FDA Approval
369.20
0.22%
Result Update:Biocon
Buy:
Biocon Ltd.
by
Axis Direct
Target: 340
Recommendation
Target
Axis Direct
We have BUY on the stock
Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.
More from Biocon Ltd.
Recommended
Five Interesting Stocks Today - September 19, 2025
The Baseline |
19 Sep 2025, 04:31PM
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch |
19 Sep 2025, 03:58PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020